info@strategicmarketresearch.com
92, An Guha Lane, Arya Samaj Gali, Sambalpur, Odisha -768001
Indian Flag  IN: +91-826-083-6500
Home » therapeutics

therapeutics

PLK Targeted Therapies Market By Drug Type (PLK1 Inhibitors, Multi-Kinase Inhibitors); By Cancer Indication (Acute Myeloid Leukemia, Prostate Cancer, Ovarian Cancer, Breast Cancer, NSCLC); By Line of Therapy (First-Line, Second-Line, Maintenance/Combo Therapy); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PLK Targeted Therapies Market is gaining traction in oncology drug development, with an inferred CAGR of around 8.5% from 2024 to 2030, valued at USD 1.1 billion in 2024<... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Gamma Delta T Cell Cancer Therapy Market By Therapy Type (Allogeneic, Autologous); By Cancer Indication (Hematologic Malignancies, Solid Tumors); By Delivery Method (Non-Engineered, Genetically Modified); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gamma Delta T Cell Cancer Therapy Market is projected to grow at a CAGR of 32.6%, starting at an estimated USD 318 million in 2024, and expected to reach aroun... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Cancer Photodynamic Therapy (PDT) Market By Product Type (Photosensitizing Agents, Light Delivery Systems); By Cancer Application (Lung Cancer, Esophageal Cancer, Bladder Cancer, Head & Neck Cancer, Skin Cancer, Others); By End User (Hospitals, Cancer Specialty Centers, Ambulatory Surgical Centers, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Photodynamic Therapy (PDT) Market is projected to grow at a CAGR of 8.9%, valued at USD 1.5 billion in 2024, and expected to reach USD 2.7 billion by 2030, according ... Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

CD5 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, Antibody-Drug Conjugates, Small Molecule Inhibitors); By Indication (Hematologic Malignancies, Autoimmune Disorders, Graft-Versus-Host Disease); By End User (Hospitals and Cancer Centers, Academic and Research Institutes, Specialty Clinics, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD5 Targeting Therapies Market is projected to expand steadily between 2024 and 2030, registering a CAGR of 10.4%, valued at around USD 1.8 billion in 2024 and expected to r... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Trigeminal Neuralgia Treatment Market By Treatment Type (Pharmacological Therapy, Surgical Procedures, Non-Invasive Therapies); By Drug Class (Anticonvulsants, Muscle Relaxants, Antidepressants, Others); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trigeminal Neuralgia Treatment Market is estimated at USD 675 million in 2024 and is projected to reach USD 1.02 billion by 2030, growing at a CAGR of 7.1%, according... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

DLL3 Targeted Therapies Market By Therapy Type (Antibody-Drug Conjugates, Bispecific Antibodies, Small Molecules, Cell Therapies); By Indication (Small Cell Lung Cancer, Large Cell Neuroendocrine Carcinoma, Other DLL3-Positive Tumors); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Cancer Specialty Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DLL3 Targeted Therapies Market is on a sharp upward trajectory — currently valued at USD 472.5 million in 2024, and expected to climb to USD 1.34 billion by 2030, ref... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

CD123 Targeted Therapy Market By Therapy Type (Antibody-Drug Conjugates, Monoclonal Antibodies, Bispecific Antibodies, CAR-T Therapies); By Application (Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Myelodysplastic Syndromes, Others); By End User (Academic & Research Hospitals, Cancer Specialty Centers, Community Hospitals & Clinics, CROs & Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD123 Targeted Therapy Market is expected to reach a value of around USD 2.1 billion in 2024 and is projected to hit nearly USD 5.3 billion by 2030, reflecting a C... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Targeted Alpha Therapy Market By Isotope Type (Actinium-225, Thorium-227, Bismuth-213, Others); By Therapeutic Area (Prostate Cancer, Leukemia, Glioblastoma, Neuroendocrine Tumors, Others); By End User (Academic Cancer Centers, Oncology Hospitals, Radiopharmacies & Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Targeted Alpha Therapy Market is projected to expand at a CAGR of 20.8%, rising from USD 1.34 billion in 2024 to an estimated USD 4.12 billion by 2030, according to Strat... Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

CD70 Targeting Therapies Market By Therapy Type (Monoclonal Antibodies, Antibody-Drug Conjugates, CAR-T Cell Therapy, Bispecific Antibodies); By Indication (Renal Cell Carcinoma, Lymphomas, Acute Myeloid Leukemia, Others); By Route of Administration (Intravenous, Subcutaneous); By End User (Hospitals, Specialty Clinics, Academic & Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD70 Targeting Therapies Market will witness a robust CAGR of 17.4%, valued at USD 1.2 billion in 2024, expected to appreciate and reach USD 3.1 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Dysmenorrhea Treatment Market By Treatment Type (NSAIDs, Hormonal Therapy, Complementary Therapies, Surgical Intervention); By Route of Administration (Oral, Injectable, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dysmenorrhea Treatment Market is expected to grow at a CAGR of 6.8% between 2024 and 2030. Valued at USD 6.8 billion in 2024, the market is projected to reach USD 10.1 bi... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Fecal Microbiota Transplants (FMT) Market By Product Type (Traditional Fecal Suspensions, Processed Microbiota Formulations); By Route of Administration (Colonoscopy, Enema, Nasogastric/Nasoduodenal Tube, Oral Capsules); By End User (Hospitals, Specialty Clinics, Research Institutes, Stool Banks); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fecal Microbiota Transplants ( FMT ) Market is poised to witness a robust CAGR of approximately 18.0% , valued at USD 1.2 billion in 20... Read More

Published Date: DEC-2025 | No Of Pages:191 | $ 4485

B-Cell Maturation Antigen (BCMA) Targeted Therapies Market By Therapy Type (CAR-T Cell Therapy, Bispecific Antibodies, Antibody-Drug Conjugates); By Indication (Multiple Myeloma, Lymphoma, Other B-cell Malignancies); By Line of Therapy (Third-line and Beyond, Earlier-line Settings); By End User (Academic Hospitals, Community Oncology Centers, Specialty Infusion Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global B - Cell Maturation Antigen ( BCMA ) Targeted Therapies Market is projected to expand at a robust CAGR of 27%, with the market valued at n... Read More

Published Date: DEC-2025 | No Of Pages:182 | $ 4485

Autosomal Dominant Polycystic Kidney Disease Market By Drug Class (Vasopressin V2 Receptor Antagonists, Somatostatin Analogs, mTOR Inhibitors, Anti-Inflammatory & Antifibrotic Agents); By Diagnostic & Monitoring Tools (MRI/CT Imaging, Genetic Testing, Biomarker Platforms); By End User (Nephrology Clinics, Specialty Hospitals, Diagnostic/Imaging Centers, Digital Health & Home Monitoring Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autosomal Dominant Polycystic Kidney Disease ( ADPKD ) Market will witness a steady CAGR of 5.9%, valued at approximately $2.7 billion in 2024 and expected to reach a... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Autosomal Dominant Optic Atrophy Market By Treatment Type (Gene Therapy, Supportive & Neuroprotective Therapies); By Diagnosis Stage (Early-Stage Diagnosis, Late-Stage Diagnosis); By End User (Academic Hospitals, Ophthalmology Clinics, Genetic Testing Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autosomal Dominant Optic Atrophy Market is estimated to reach around USD 143 million in 2024 and is projected to grow at a CAGR of 9.6% , ultimately surpassing USD 248 million b... Read More

Published Date: DEC-2025 | No Of Pages:161 | $ 4485

Autoimmune Encephalitis Treatment Market By Treatment Type (Acute Immunotherapy, Maintenance Immunotherapy, Adjunctive Care); By Antibody Subtype (Anti-NMDA, LGI1, CASPR2, GABA, AMPA, Others); By End User (Tertiary Hospitals, General Hospitals, Neurology Clinics, Pediatric Centers, Infusion Facilities); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autoimmune Encephalitis Treatment Market is projected to grow at a robust CAGR of 8.1% , with an estimated value of USD 3.2 billion in 2024 and expected to reach USD 5.1 billion... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Atypical Hemolytic Uremic Syndrome Market By Drug Class (C5 Inhibitors, C3 Inhibitors, MASP-2 Inhibitors, RNAi Therapies, Others); By Route of Administration (Intravenous, Subcutaneous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online Platforms); By End User (Hospitals, Specialty Clinics, Pediatric Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Atypical Hemolytic Uremic Syndrome (Ahus) Market will witness a steady Compound Annual Growth Rate ( CAGR ) of 7.8 %, valued at around $1.3 bi... Read More

Published Date: DEC-2025 | No Of Pages:184 | $ 4485

Atrophic Vaginitis Treatment Market By Treatment Type (Hormonal [Estrogen Tablets, Creams, Rings, SERMs], Non-Hormonal [Moisturizers, Hyaluronic Acid, Laser & RF Devices]); By Route of Administration (Topical, Oral, Device-Based); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online & Telehealth Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Atrophic Vaginitis Treatment Market is projected to reach $3.1 billion by 2030 , up from $1.9 billion in 2024 , growing at a CAGR of 8.5% over the forecast period, according... Read More

Published Date: DEC-2025 | No Of Pages:181 | $ 4485

Astrocytoma Market By Grade (Low-Grade [Grade I & II], High-Grade [Grade III & IV]); By Treatment (Surgery, Radiation Therapy, Chemotherapy, Targeted Therapy); By End User (Hospitals, Oncology Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Astrocytoma Market will witness a steady CAGR of 5.8%, valued at USD 2.1 billion in 2024, and projected to reach USD 3.0 billion by 2030 , according to Strategic Market R... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Aromatase Inhibitors Market By Drug Type (Anastrozole, Letrozole, Exemestane); By Application (Breast Cancer, Ovarian Cancer, Male Breast Cancer, Endometriosis, Fertility Treatment – PCOS); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aromatase Inhibitors Market is projected to grow at a CAGR of 5.8% , valued at USD 2.7 billion in 2024 , and expected to reach USD 3.8 billion by 2030 , as per modeli... Read More

Published Date: DEC-2025 | No Of Pages:150 | $ 4485

Angiotensin-Converting Enzyme (ACE) Inhibitors Market By Product Type (Lisinopril, Enalapril, Ramipril, Captopril, Benazepril, Others); By Application (Hypertension, Heart Failure, Myocardial Infarction, Diabetic Nephropathy, CKD, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Angiotensin - Converting Enzyme Inhibitors Market is projected to expand at a CAGR of 5.8% , reaching nearly USD 8.6 billion by 2030 , up from USD 5.... Read More

Published Date: DEC-2025 | No Of Pages:186 | $ 4485

Angioimmunoblastic T-cell Lymphoma Market By Therapy Type (Chemotherapy Regimens, Targeted Therapies, Monoclonal Antibodies & Biologics, Stem Cell Transplant); By Line of Therapy (First-Line, Second-Line and Beyond); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Angioimmunoblastic T -Cell Lymphoma Market is projected to expand at a CAGR of 8.1% , moving from an estimated USD 1.1 billion in 2024 to nearly ... Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

Aneurysmal Subarachnoid Hemorrhage Market By Treatment Type (Endovascular Coiling, Surgical Clipping, Pharmacologic Therapy); By Drug Class (Calcium Channel Blockers, Vasodilators, Endothelin Receptor Antagonists, Neuroprotective Agents); By End User (Tertiary Stroke Centers, General Hospitals, Academic Medical Centers, Ambulatory Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aneu rysmal Subarachnoid Hemorrhage Market is estimated to be worth USD 1.74 billion in 2024 , and it's projected to reach around USD 2.43 billion by 2030 , gr... Read More

Published Date: DEC-2025 | No Of Pages:156 | $ 4485

ANCA Associated Vasculitis Market By Disease Type (Granulomatosis with Polyangiitis, Microscopic Polyangiitis, Eosinophilic Granulomatosis with Polyangiitis); By Treatment Class (Corticosteroids, Immunosuppressants, Biologic Therapies, Plasma Exchange & Adjunct Therapies); By Route of Administration (Oral, IV, Subcutaneous); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global ANCA Associated Vasculitis (AAV) Market is forecast to expand steadily, with an inferred CAGR of 6.1% , valued at roughly USD 1.6 billion in 2024 and projected to surpass Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Alport Syndrome Market By Product Type (Pharmacological Therapies, Gene and Cell Therapies, Supportive Care); By Route of Administration (Oral, Intravenous, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alport Syndrome Market is set to grow at a CAGR of 6.8% , valued at USD 412 million in 2024 , and projected to reach nearly USD 615 million by 2030 , according... Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Alpha-synuclein Inhibitors Market By Drug Class (Small Molecules, Monoclonal Antibodies, Peptide Inhibitors); By Mechanism of Action (Aggregation Inhibitors, Misfolding Blockers, Clearance Enhancers); By Indication (Parkinson’s Disease, Multiple System Atrophy, Lewy Body Dementia); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha-Synuclein Inhibitors Market will witness a strong CAGR of 21.8% , valued at USD 1.2 billion in 2024 , and is projected to reach USD 3.9 billion by 2030 , accord... Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Alpha-1 Antitrypsin Deficiency Market By Therapy Type (Augmentation Therapy, Gene Therapy, Small Molecule Drugs); By Route of Administration (Intravenous, Inhalation, Subcutaneous); By Disease Manifestation (Pulmonary, Liver, Others); By End User (Hospitals, Specialty Clinics, Home Infusion Services, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha-1 Antitrypsin Deficiency Market is projected to expand at a steady CAGR of 6.3%, reaching approximately USD 4.1 billion by 2030 , up from an estimated USD 2.8 billion in 2... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Alpha Thalassemia Treatment Market By Treatment Type (Blood Transfusions, Iron Chelation Therapy, Gene Therapy, HbF Inducers); By Disease Type (Alpha Thalassemia Trait, Hemoglobin H Disease, Hb Bart’s Hydrops Fetalis); By Route of Administration (Parenteral, Oral); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alpha Thalassemia Treatment Market is projected to expand at a CAGR of 6.9% between 2024 and 2030. The market is valued at approximately USD 536.4 million in 2024 and is expected t... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

Alopecia Areata Market By Treatment Type (Topical Treatments, Oral/Systemic Treatments, Injectable Therapies, Biologics/Pipeline Drugs); By Patient Age Group (Pediatric, Adult); By End User (Hospitals and Specialty Clinics, Outpatient/Community Clinics, Telemedicine/Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alopecia Areata Market will witness a robust CAGR of 7.8 %, valued at an estimated USD 3.2 billion in 2024 , and expected to reach around USD 5.0 bil... Read More

Published Date: DEC-2025 | No Of Pages:185 | $ 4485

Alagille Syndrome Market By Treatment Type (Pharmacological Therapies, Surgical Interventions, Supportive Therapies); By Route of Administration (Oral, Parenteral/Hospital-Based); By End User (Hospitals & Specialty Centers, Diagnostic Laboratories, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alagille Syndrome Market will witness a steady CAGR of 7.5% , valued at around USD 0.46 billion in 2024 and expected to reach nearly USD 0.76 billion by 2030 ,... Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Aicardi Goutières Syndrome Market By Treatment Type (Symptomatic Therapy, Experimental/Investigational Therapies); By Route of Administration (Oral, Parenteral, Emerging Routes); By End User (Specialty Hospitals, Academic & Research Institutes, Diagnostic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aicardi Goutières Syndrome ( AGS ) Market will witness a steady CAGR of 7.8% , valued at USD 92 million in 2024 , and is projected to reach USD 154 m... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Age Related Vision Dysfunction Market By Disorder Type (AMD, Cataracts, Glaucoma, Diabetic Retinopathy, Presbyopia); By Treatment Modality (Pharmacological, Surgical, Assistive Technologies, Diagnostic Imaging); By End User (Ophthalmology Clinics, Hospitals & ASCs, Retail Optometry Chains, Home-Based Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Age-Related Vision Dysfunction Market is projected to grow steadily between 2024 and 2030, with an Compound Annual Growth Rate ( CAGR ) Of 6.8% . It’s estimated to be worth ... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Advanced Renal Cell Carcinoma Market By Therapy Class (Tyrosine Kinase Inhibitors, mTOR Inhibitors, Immune Checkpoint Inhibitors, HIF-2α Inhibitors, Bispecifics and Others); By Line of Treatment (First-Line, Second-Line, Later Lines); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Advanced Renal Cell Carcinoma Market will witness a CAGR of 7.8% , valued at USD 9.6 billion in 2024 , and projected to reach USD 15.1 billion by 2030 , according to Stra... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Adrenoleukodystrophy (ALD) Market By Disease Type (Cerebral ALD, Adrenomyeloneuropathy, Addison-only ALD); By Treatment Modality (Gene Therapy, Stem Cell Transplant, Hormone Replacement, Supportive Therapy, Diagnostics); By End User (Children’s Hospitals, Neurology Clinics, Diagnostic Labs, Endocrinology Centers, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adrenoleukodystrophy (ALD) Market is gaining attention as diagnostic technologies, gene therapies, and newborn screening programs converge. Valued at USD 505 million in 2024... Read More

Published Date: DEC-2025 | No Of Pages:165 | $ 4485

Adrenal Crisis Management Market By Product Type (Corticosteroid Injections, Auto-injectors & Prefilled Syringes, Oral Corticosteroids & Adjunct Therapies); By Route of Administration (Intravenous, Intramuscular / Subcutaneous); By End User (Hospitals & Emergency Departments, Ambulatory Clinics, Homecare, EMS Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adrenal Crisis Management Market is projected to expand steadily, with an inferred CAGR of 6.1% , rising from an estimated USD 3.2 billion in 2024 to arou... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Acute Respiratory Distress Syndrome (ARDS) Treatment Market By Product Type (Mechanical Ventilation Systems, Extracorporeal Membrane Oxygenation, Pharmacologic Therapies, Adjunctive Care Tools); By Route of Administration (Intravenous, Inhalation, Emerging Routes); By End User (Hospitals & Intensive Care Units, Specialty & Academic Centers, General Hospitals, Emergency & Ambulatory Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Respiratory Distress Syndrome (ARDS) Treatment Market will witness a robust CAGR of 6.2% , valued at USD 6.2 billion in 2024 , and ... Read More

Published Date: DEC-2025 | No Of Pages:198 | $ 4485

Acute Pancreatitis Market By Treatment Type (Supportive Care, Pharmacotherapy, Interventional & Surgical Procedures); By Etiology (Gallstone-Induced, Alcohol-Induced, Hypertriglyceridemia-Induced, Other/Idiopathic); By End User (Hospitals, Specialty Gastroenterology Centers, Ambulatory Surgical Centers, Long-Term Care Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Pancreatitis Market is projected to grow at a steady pace between 2024 and 2030, expanding from an estimated USD 5.8 billion in 2024 to nearly USD 8.6 billio... Read More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Acute on Chronic Liver Failure Market By Treatment Type (Pharmacological Therapy, Liver Support Systems, Organ Transplantation, Plasma Exchange); By End User (Tertiary Care Hospitals, Transplant Centers, Academic Medical Institutions, Specialty Liver Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute on Chronic Liver Failure ( ACLF ) Market is expected to grow at a CAGR of 9.0% , with a total valuation of approxi... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Acute Ocular Pain Market By Treatment Type (Topical NSAIDs, Topical Corticosteroids, Local Anesthetics, Neuropathic Pain Agents, Biologics); By Indication (Post-Operative Eye Pain, Corneal Abrasions & Injuries, Uveitis & Inflammatory Episodes, Chemical Burns, Neuropathic Ocular Pain); By Route of Administration (Topical Drops, Injectables, Oral Medications, Ocular Implants/Inserts); By End User (Ophthalmology Clinics, Hospital Emergency Departments, Ambulatory Surgical Centers, Retail Pharmacies, Teleophthalmology Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Ocular Pain Market is projected to grow at a CAGR of 6.4% , estimated at USD 2.1 billion in 2024 and likely to reach around USD 3.1 billion by 2030 ... Read More

Published Date: DEC-2025 | No Of Pages:195 | $ 4485

Acute Gout Flare Therapeutics Market By Drug Class (NSAIDs, Colchicine, Corticosteroids, Biologic Agents, Others); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Gout Flare Therapeutics Market is projected to advance steadily, reaching an estimated value of USD 4.2 billion in 2024 and expanding to USD 6.1 billion by 2... Read More

Published Date: DEC-2025 | No Of Pages:171 | $ 4485

Acute Coronary Syndrome Market By Type (STEMI, NSTEMI, Unstable Angina); By Drug Class (Antiplatelet Agents, Anticoagulants, Statins, Beta-Blockers, ACE Inhibitors/ARBs, Thrombolytics); By Device Type (Coronary Stents, Balloon Catheters, IVUS/OCT Imaging, Thrombectomy Devices, Diagnostics); By End User (Hospitals with PCI Facilities, EMS, Secondary Hospitals, Cardiology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Coronary Syndrome Market is set to grow at a robust pace, with a projected CAGR of 6.8% from 2024 to 2030 . Valued at approximately USD 11.2... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market By Drug Class (Oxazolidinones, Lipoglycopeptides, Lipopeptides, Beta-lactams & Cephalosporins, Others); By Route of Administration (Intravenous, Oral, Long-Acting Injectable); By Infection Type (Cellulitis, Wounds, Abscesses, Trauma); By End User (Hospitals, ASCs, Outpatient Clinics, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acute Bacterial Skin and Skin Structure Infections Market is projected to expand steadily, valued at approximately USD 5.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Acid Sphingomyelinase Deficiency (ASMD) Market By Product Type (Enzyme Replacement Therapy, Gene Therapy Candidates, Supportive Care); By Application (Type A – Infantile Neurovisceral, Type B – Chronic Visceral, Type A/B Intermediate); By End User (Specialty & Tertiary Hospitals, Academic & Research Institutes, Home Infusion & Specialty Pharmacies, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Acid Sphingomyelinase Deficiency Market will witness a strong growth trajectory, valued at USD 450 million in 2024 and projected to reach approximately Read More

Published Date: DEC-2025 | No Of Pages:170 | $ 4485

Achondroplasia Market By Therapy Type (CNP Analogs, FGFR Inhibitors, Adjunctive & Supportive Care); By Patient Age Group (Pediatrics, Adults); By Route of Administration (Subcutaneous Injections, Oral Therapies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Achondroplasia Market will expand steadily between 2024 and 2030, with the market estimated at USD 1.1 billion in 2024 and projected to reach around USD 2.4 billio... Read More

Published Date: DEC-2025 | No Of Pages:199 | $ 4485

Abdominal Aortic Aneurysm Treatment Market By Treatment Type (Endovascular Aneurysm Repair, Open Surgical Repair); By Product Type (Stent Grafts, Catheters & Guidewires, Closure Devices & Balloons, Surgical Instruments); By End User (Hospitals & Surgical Centers, Outpatient Vascular Clinics, Military/Trauma Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Abdominal Aortic Aneurysm Treatment Market is projected to reach $ 5.70 billion by 2030 , growing from an estimated $ 3.5Read More

Published Date: DEC-2025 | No Of Pages:163 | $ 4485

LAG-3 Targeting Therapy Market By Therapy Type (Monotherapy, Combination Therapy); By Indication (Melanoma, Non-Small Cell Lung Cancer, Triple-Negative Breast Cancer, Head & Neck Squamous Cell Carcinoma, Other Solid Tumors, Hematologic Malignancies); By End User (Hospitals, Specialty Cancer Centers, Academic Research Institutes, Clinical Trial Sites); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global LAG-3 Targeting Therapy Market will witness a strong CAGR of 24.1%, valued at an estimated USD 1.37 billion in 2024 and projected to exce... Read More

Published Date: DEC-2025 | No Of Pages:200 | $ 4485

PRMT5 Targeted Therapies Market By Drug Type (Small Molecule Inhibitors, Allosteric Inhibitors, Protein Degraders); By Application (NSCLC, Glioblastoma, Pancreatic Cancer, Mantle Cell Lymphoma, AML, MDS); By Route of Administration (Oral, Intravenous); By End User (Academic Cancer Centers, Oncology Clinics, Community Hospitals, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global PRMT5 Targeted Therapies Market is poised to expand at a robust CAGR of 28.4%, valued at approximately USD 412 million in 2024, and proje... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

CD39 Targeted Therapies Market By Drug Type (Monoclonal Antibodies, Small Molecule Inhibitors); By Therapeutic Application (Oncology, Autoimmune Disorders, Combination Therapy); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global CD39 Targeted Therapies Market is projected to expand at a CAGR of 16.8%, rising from USD 427.0 million in 2024<... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Biotherapeutics Market By Product Type (Monoclonal Antibodies, Recombinant Proteins, Cell Therapy Products, Gene Therapies, Vaccines); By Application (Oncology, Autoimmune Diseases, Rare Genetic Disorders, Infectious Diseases, Neurological Disorders); By Route of Administration (Intravenous, Subcutaneous, Oral & Others); By End User (Academic & Specialty Hospitals, General Hospitals, Infusion Clinics, Specialty Pharmacies & Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biotherapeutics Market is projected to expand steadily at a CAGR of 8.6%, valued at USD 356.7 billion in 2024, and expec... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Hormonal Contraceptives Market By Product Type (Combined Hormonal Contraceptives, Progestin-Only Contraceptives); By Route of Administration (Oral, Transdermal, Subdermal, Intramuscular, Vaginal); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hormonal Contraceptives Market is projected to reach $29.7 billion by 2030, up from an estimated $21.3 billion in 2024, growing at a CAGR of 5.7% during t... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Venous Thromboembolism (VTE) Treatment Market By Product Type (Anticoagulants, Thrombolytic Agents, Mechanical Thrombectomy Devices, Vena Cava Filters); By Route of Administration (Oral, Injectable, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Venous Thromboembolism (VTE) Treatment Market will witness a steady CAGR of around 6.5%, valued at about USD 10.8 billion in 2024, and ex... Read More

Published Date: DEC-2025 | No Of Pages:175 | $ 4485

Mitochondrial Disease Therapies Market By Therapy Type (Small Molecules, Gene Therapy, Enzyme Replacement, Others); By Route of Administration (Oral, Injectable/Intravenous, Others); By End User (Hospitals, Specialty Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Mitochondrial Disease Therapies Market will expand steadily at an CAGR of 9.1%, valued at USD 1.1 billion in 2024, and projected to reach USD 2.0 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:188 | $ 4485

Pulmonary Embolism Therapeutics Market By Drug Class (DOACs, LMWH, Unfractionated Heparin, Vitamin K Antagonists, Thrombolytics); By Route of Administration (Oral, Injectable); By Disease Severity (Low-Risk, Submassive, Massive); By End User (Hospitals, Specialty Clinics, Retail Pharmacies, Home Healthcare Providers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pulmonary Embolism Therapeutics Market is projected to grow at a CAGR of 6.3% , valued at USD 2.7 billion in 2024 and anticipated to reach approximately USD 4.1 bi... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Dimpleplasty Market By Procedure Type (Suturing Technique, Excisional Technique); By Gender (Male, Female); By Age Group (18–25, 26–35, 36–50, 50+); By End User (Cosmetic Surgery Clinics, Aesthetic Dermatology Practices, Hospital-Based Cosmetic Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Dimpleplasty Market is projected to grow at a steady CAGR of 9.6% , valued at USD 74.6 million in 2024 and expected to surpass US... Read More

Published Date: DEC-2025 | No Of Pages:172 | $ 4485

Brachioplasty Market By Technique (Traditional Brachioplasty, Mini Brachioplasty, Extended Brachioplasty, Non-Invasive Techniques); By Gender (Male, Female); By End User (Hospitals, Ambulatory Surgical Centers, Aesthetic Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Brachioplasty Market will witness a solid CAGR of 8.2% , valued at USD 1.3 billion in 2024 , and projected to reach USD 2.1 billion by 2030 , according to... Read More

Published Date: DEC-2025 | No Of Pages:173 | $ 4485

Neoantigen Targeted Therapy Market By Therapy Type (Personalized Neoantigen Vaccines, T-cell Based Therapies); By Cancer Indication (Melanoma, NSCLC, Glioblastoma, Bladder Cancer, Colorectal Cancer, Others); By Delivery Platform (mRNA, Peptide, Dendritic Cell, DNA-based); By End User (Academic Medical Centers, Specialty Cancer Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neoantigen Targeted Therapy Market is projected to expand at a remarkable growth rate, estimated at USD 1.9 billion in 2024 and expected to reach USD 8.5 billion by 2030, ... Read More

Published Date: DEC-2025 | No Of Pages:184 | $ 4485

Theranostics Market By Therapeutic Area (Oncology, Neurology, Cardiology, Others); By Technology Platform (Radiopharmaceuticals, Nanoparticle Systems, Antibody-Drug Conjugates, RNA-Based Platforms); By End User (Academic & Research Institutions, Specialty Clinics, Tertiary Hospitals, CDMOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Theranostics Market is poised for strong growth between 2024 and 2030, with a projected CAGR of 10.4% , growing from USD 13.6 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

Non-Muscle Invasive Bladder Cancer (NMIBC) Market By Therapy Type (Intravesical Therapy, Immuno-Oncology Agents, Surgery & Resection [TURBT], Emerging Therapies); By Route of Administration (Intravesical, Intravenous/Oral); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Muscle Invasive Bladder Cancer (NMIBC) Market will expand steadily at an estimated CAGR of 6.8% , moving from a valuation of USD 2.9 billion in 2024 t... Read More

Published Date: DEC-2025 | No Of Pages:159 | $ 4485

Cancer Metabolism Based Therapeutics Market By Therapeutic Class (Enzyme Inhibitors, Immunometabolism Modulators, Multi-Pathway Inhibitors); By Cancer Type (Glioblastoma, Pancreatic Cancer, Acute Myeloid Leukemia, Renal Cell Carcinoma, Non-Small Cell Lung Cancer); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cancer Metabolism Based Therapeutics Market is expected to grow at a CAGR of 10.8% , reaching a projected value of $6.7 billion by 2030 , up from $3.5 billion in 2... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Functional Endoscopic Sinus Surgery (FESS) Market By Product Type (Endoscopes, Powered Surgical Instruments, Balloon Dilation Systems, Navigation Systems); By Indication (Chronic Rhinosinusitis, Nasal Polyposis, Fungal Sinusitis & Tumors); By End User (Hospitals, ENT Clinics & Specialty Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Functional Endoscopic Sinus Surgery (FESS) Market is projected to grow at a CAGR of 6.8% , with an estimated valuation of USD 3.5 billion in 2024<... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Allogeneic Cell Therapy Market By Cell Type (Hematopoietic Stem Cells, Mesenchymal Stem Cells, NK Cells, T Cells, Others); By Therapeutic Application (Oncology, Neurology, Autoimmune Disorders, Cardiovascular, Orthopedics, Others); By Source (Bone Marrow, Peripheral Blood, Umbilical Cord Blood, iPSCs); By End User (Hospitals & Specialty Clinics, Academic & Research Institutes, Biopharma & CMOs, Regenerative Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Allogeneic Cell Therapy Market will witness a robust CAGR of around 18.5% , valued at USD 4.7 billion in 2024 and projected to reach USD 13.2 bill... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Novel T-Cell Immunotherapy Market By Therapy Type (CAR-T Cell Therapy, TCR-T Cell Therapy, Tumor-Infiltrating Lymphocytes, Allogeneic T-Cell Therapy); By Indication (Hematologic Malignancies, Solid Tumors, Autoimmune Disorders); By Cell Source (Autologous, Allogeneic); By End User (Academic & Research Institutes, Specialty Cancer Centers, CDMOs, Community Oncology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Novel T-Cell Immunotherapy Market is poised for rapid expansion, valued at USD 6.8 billion in 2024 and projected to reach USD 18.9 billion by 2030 , growi... Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Vascular Disrupting Agents (VDA) Market By Type (Tubulin-Binding Agents, Non-Tubulin-Binding Agents); By Cancer Indication (Non-Small Cell Lung Cancer, Ovarian Cancer, Colorectal Cancer, Head and Neck Squamous Cell Carcinoma, Sarcomas); By Route of Administration (Intravenous, Intratumoral); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Vascular Disrupting Agents (VDA) Market is anticipated to expand at a CAGR of 8.5% , moving from USD 1.9 billion in 2024... Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

DNA Damage Response (DDR) Market By Therapeutic Class (PARP Inhibitors, ATM/ATR Inhibitors, WEE1 Inhibitors, CHK1/CHK2 Inhibitors, POLQ and Others); By Indication (Ovarian Cancer, Breast Cancer, Prostate Cancer, Pancreatic Cancer, Others); By End User (Academic & Research Institutes, Cancer Hospitals, Private Oncology Clinics, Diagnostic Labs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global DNA Damage Response (DDR) Market is projected to grow steadily, with an estimated value of USD 5.8 billion in 2024 and forecasted to reach USD 11.2 billion by 2030... Read More

Published Date: DEC-2025 | No Of Pages:152 | $ 4485

Peripheral Neuropathy Treatment Market By Treatment Type (Pharmacological Therapies, Medical Devices, Complementary Interventions); By Indication (Diabetic Neuropathy, Chemotherapy-Induced Neuropathy, Post-Herpetic Neuralgia, Alcohol-Related Neuropathy, Idiopathic Neuropathy); By Route of Administration (Oral, Topical, Device-Based); By End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Homecare & Telehealth); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peripheral Neuropathy Treatment Market will witness a steady CAGR of 6.8% , valued at USD 2.47 billion in 2024 , and projected to reach USD 3.68 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:178 | $ 4485

Joint Pain Injections Market By Product Type (Corticosteroid Injections, Hyaluronic Acid Injections, PRP Injections, Stem Cell-Based Injections, Combination & Other Biologics); By Joint/Application (Knee, Hip, Shoulder, Ankle, Elbow, Others); By End User (Hospitals, Orthopedic Clinics, ASCs, Sports Medicine & Rehab Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Joint Pain Injections Market is projected to grow at a CAGR of 6.8% , reaching approximately USD 8.1 billion in 2030 , up from an estimated USD 5.... Read More

Published Date: DEC-2025 | No Of Pages:190 | $ 4485

Non-Hormonal Contraceptives Market By Product Type (Barrier Methods, Copper IUDs, Spermicides & Vaginal Gels, Fertility Awareness & Digital Tools); By Distribution Channel (Hospitals & Clinics, Retail Pharmacies & Drugstores, Online Platforms); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Non-Hormonal Contraceptives Market is projected to expand steadily between 2024 and 2030, with an estimated valuation of USD 8.7 billion in 2024 and expected to reach arou... Read More

Published Date: DEC-2025 | No Of Pages:167 | $ 4485

TCR Therapy Market By Target Antigen Type (Cancer-Testis Antigens, Neoantigens, Viral Antigens); By Indication (Synovial Sarcoma, Non-Small Cell Lung Cancer, Ovarian Cancer, Colorectal Cancer, Others); By Technology Platform (Naturally Derived TCRs, Affinity-Enhanced TCRs, Gene-Edited TCRs, Allogeneic TCR T cells); By End User (Academic Cancer Centers, Specialized Immunotherapy Clinics, Tertiary Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global TCR Therapy Market is projected to grow at a robust CAGR of 38.4% , reaching USD 8.9 billion by 2030 , up from an estimated USD 0... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Sciatica Treatment Market By Treatment Type (Drug Therapy, Physical Therapy & Rehabilitation, Interventional Procedures, Surgical Interventions, Alternative Therapies); By Route of Administration (Oral, Injectable, Topical, Transdermal); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Pain Clinics, Rehabilitation Centers, Homecare & Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Sciatica Treatment Market will witness a steady CAGR of 5.4%, valued at USD 7.8 billion in 2024 and projected to reach nearly USD 10.7 billion by 2030, ac... Read More

Published Date: DEC-2025 | No Of Pages:162 | $ 4485

Short Bowel Syndrome Market By Drug Class (GLP-2 Analogues, Growth Hormones, Antidiarrheals, Proton Pump Inhibitors, Others); By Route of Administration (Parenteral, Oral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Short Bowel Syndrome Market will witness a CAGR of 8.7 %, valued at USD 1.62 billion in 2024 , and projected to reach USDRead More

Published Date: DEC-2025 | No Of Pages:192 | $ 4485

Neovaginal Surgery Market By Surgical Technique (Penile Inversion, Sigmoid Colon, Peritoneal, Skin/Buccal Graft); By Indication (Gender-Affirming Surgery, Congenital Anomalies, Reconstructive Oncology/Trauma); By End User (Academic Medical Centers, Specialty Clinics, Public Hospitals, Congenital Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neovaginal Surgery Market Is projected to grow at a robust CAGR of 9.8% , reaching a total market value of approximately USD 3.2 billion in 2030 , up from... Read More

Published Date: DEC-2025 | No Of Pages:166 | $ 4485

Appendicitis Treatment Market By Treatment Type (Open Appendectomy, Laparoscopic Appendectomy, Robotic-Assisted Appendectomy, Non-Surgical Antibiotic Therapy); By Route of Administration (Intravenous, Oral, Parenteral); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Appendicitis Treatment Market will witness a steady CAGR of 7.6%, valued at USD 7.8 billion in 2024 and expected to reach USD 12.... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Biofilms Treatment Market By Product Type (Topical Agents, Enzymatic Disruptors, Systemic Antibiotics, Surface Coatings, Novel Therapeutics); By Application (Chronic Wounds, Orthopedic Implant Infections, Cardiovascular Devices, Dental & Oral Health, Urology); By End User (Hospitals & Surgical Centers, Wound Care Clinics, Dental Clinics, Veterinary & Military Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Biofilms Treatment Market is projected to grow at a CAGR of 8.6% between 2024 and 2030. The market is estimated to be worth USD 3.1 billion in 2024 and is... Read More

Published Date: DEC-2025 | No Of Pages:189 | $ 4485

Leptospirosis Market By Product Type (Diagnostics, Therapeutics, Vaccines); By Application (Human Health, Animal Health); By End User (Hospitals & Clinics, Diagnostic Laboratories, Veterinary Clinics & Farms, Public Health Agencies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Leptospirosis Market is poised to expand at a CAGR of 5.9% , reaching approximately USD 920 million by 2030 , up from an estimated USD 650 million... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Cartilage Degeneration Market By Treatment Type (Non-Surgical [Pharmacological, Biologics, Injections], Surgical [Implants, Grafts, Regenerative Therapies]); By Application (Knee, Hip, Ankle, Shoulder, Others); By End User (Hospitals, Specialty Orthopedic & Sports Medicine Clinics, Ambulatory Surgical Centers, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cartilage Degeneration Market will witness a steady CAGR of 6.8%, valued at USD 9.7 billion in 2024, expected to reach USD 15.3 billion by 2030, according... Read More

Published Date: DEC-2025 | No Of Pages:154 | $ 4485

Gerontology Market By Product & Service Type (Assistive Technologies, Geriatric Pharmaceuticals, Long-Term Care Services, Digital Health & Monitoring Tools, Wellness & Preventive Services); By Application (Chronic Disease Management, Cognitive Health and Dementia Care, Mobility and Fall Prevention, Mental Health Support, End-of-Life and Palliative Care, Preventive and Lifestyle Medicine); By End User (Hospitals and Geriatric Clinics, Long-Term Care Facilities, Home-Based Care Settings, Community Health Centers, Individual Consumers and Families); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gerontology Market will witness a steady CAGR of 6.3% , valued at USD 298.7 billion in 2024 , and is projected to reach USD 455.1 billion by 2030 , accord... Read More

Published Date: DEC-2025 | No Of Pages:153 | $ 4485

Lumpectomy Market By Surgery Type (Standard Lumpectomy, Oncoplastic Lumpectomy, Image-Guided Lumpectomy); By Technology Used (Wire Localization, Radiofrequency & Magnetic Seed Localization, Vacuum-Assisted Excision Devices); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Cancer Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lumpectomy Market will witness a steady CAGR of 6.1%, valued at USD 2.3 billion in 2024 , expected to appreciate and reach USD 3.3 billion by 2030, confir... Read More

Published Date: DEC-2025 | No Of Pages:179 | $ 4485

Dupixent Market By Indication (Atopic Dermatitis, Asthma, Chronic Rhinosinusitis with Nasal Polyps, Eosinophilic Esophagitis, Prurigo Nodularis); By Age Group (Adults, Adolescents, Pediatrics); By Delivery Mode (Prefilled Syringes, Auto-injectors); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dupixent Market is projected to grow at a compound annual growth rate (CAGR) of 13.8% , with an estimated value of USD 9.8 billion in 2024Read More

Published Date: DEC-2025 | No Of Pages:164 | $ 4485

Lysosomal Storage Disease Treatment Market By Disease Type (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidoses, Niemann-Pick Disease, Others); By Treatment Type (Enzyme Replacement Therapy, Substrate Reduction Therapy, Pharmacological Chaperones, Gene Therapy); By Route of Administration (Intravenous, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Home Infusion Services); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Lysosomal Storage Disease ( LSD ) Treatment Market will witness a robust CAGR of 9.1%, valued at approximately USD 2.3 billion in 2024 an... Read More

Published Date: DEC-2025 | No Of Pages:155 | $ 4485

Diabetic Ketoacidosis Treatment Market By Treatment Type (Insulin Therapy, Fluid & Electrolyte Replacement, Adjunctive Therapies, Glucose Monitoring); By Route of Administration (Intravenous, Subcutaneous, Oral); By End User (Hospitals, Emergency Departments, Ambulatory Care Centers, Diabetes Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Diabetic Ketoacidosis Treatment Market will witness a steady CAGR of 6.4%, valued at approximately USD 3.6 billion in 2024 , expected to reach USD 5.2 billion by 2... Read More

Published Date: DEC-2025 | No Of Pages:187 | $ 4485

Binge-Eating Disorder Treatment Market By Treatment Type (Pharmacotherapy, Cognitive Behavioral Therapy, Digital Therapeutics, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By End User (Hospitals, Specialty Clinics, Outpatient Therapy Centers, Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Binge - Eating Disorder Treatment Market will expand at a CAGR of 6.8% , valued at USD 520 million in 2024 and projected... Read More

Published Date: DEC-2025 | No Of Pages:157 | $ 4485

Tremfya (Guselkumab) Market By Product Type (Injectable Biologic); By Application (Plaque Psoriasis, Psoriatic Arthritis, Pipeline Indications – Crohn’s Disease, Ulcerative Colitis); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Retail & Specialty Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tremfya Market is projected to expand consistently between 2024 and 2030, with an CAGR of 9.1%. The market is valued at USD 3.1 billion in 2024 and is expected to reach ne... Read More

Published Date: DEC-2025 | No Of Pages:196 | $ 4485

Naltrexone and Buprenorphine Market By Product Type (Naltrexone, Buprenorphine); By Route of Administration (Oral, Transdermal/Implants, Injectables); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Naltrexone and Buprenorphine Market will witness a steady CAGR of 6.8% , valued at around USD 3.6 billion in 2024 , and projected to reach USD 5.4 billion by 2030<... Read More

Published Date: DEC-2025 | No Of Pages:186 | $ 4485

Cyclosporine Market By Therapeutic Application (Transplantation, Autoimmune Disorders, Ophthalmology); By Formulation Type (Oral Capsules, Injectables, Topical Formulations); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cyclosporine Market will witness a steady CAGR of 6.1%, valued at approximately USD 1.53 billion in 2024 , and expected to reach USD 2.19 billion by 2030 ... Read More

Published Date: DEC-2025 | No Of Pages:160 | $ 4485

Thoracic Aortic Aneurysm Market By Product Type (Stent Grafts, Synthetic Grafts, Surgical Instruments, Imaging Systems); By Approach (Endovascular Repair [TEVAR], Open Surgical Repair); By Indication (Ascending Aortic Aneurysms, Descending Thoracic Aneurysms, Thoracoabdominal Aneurysms); By End User (Hospitals, Specialty Cardiac Centers, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Thoracic Aortic Aneurysm Market will witness a steady CAGR of 8.4%, valued at USD 2.5 billion in 2024 and expected to reach USD 4.1 billion by 2030 , acco... Read More

Published Date: DEC-2025 | No Of Pages:177 | $ 4485

Anti-Biofilm Wound Dressing Market By Product Type (Foam Dressings, Hydrofiber Dressings, Alginate Dressings, Combination Dressings); By Wound Type (Chronic Wounds, Acute Wounds); By End User (Hospitals, Specialty Wound Care Clinics, Ambulatory Surgical Centers, Home Healthcare, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Anti-Biofilm Wound Dressing Market will witness a robust CAGR of 6%, valued at USD 790 million in 2024 , expected to appreciate and reach more than USD 1.1 billion... Read More

Published Date: DEC-2025 | No Of Pages:193 | $ 4485

Male Urinary Incontinence Market By Product Type (Catheters, Artificial Urinary Sphincters, Male Slings, Absorbent Products, External Clamps); By Application (Stress Incontinence, Urge Incontinence, Overflow Incontinence, Mixed Incontinence); By End User (Hospitals, Specialty Urology Clinics, Ambulatory Surgical Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Male Urinary Incontinence Market will witness a CAGR of 6.8%, valued at USD 3.4 billion in 2024 , expected to appreciate and reach nearly USD 5.1 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:180 | $ 4485

Hemangioma Treatment Market By Therapy Type (Pharmacological Therapy, Laser Therapy, Surgical and Interventional Approaches); By Application (Cutaneous Hemangiomas, Visceral Hemangiomas, Mixed and Complicated Hemangiomas); By End User (Hospitals, Specialty Dermatology and Pediatric Clinics, Ambulatory Surgical Centers, Community Health Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemangioma Treatment Market will grow at a CAGR of 6.8% , valued at USD 4.9 billion in 2024 , and projected to reach USD 7.7 bill... Read More

Published Date: DEC-2025 | No Of Pages:197 | $ 4485

Drug Repurposing Market By Therapeutic Area (Oncology, Neurology, Infectious Diseases, Cardiovascular, Autoimmune Disorders); By Drug Type (Generic Drugs, Off-Patent Drugs, Patented Drugs); By End User (Pharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Drug Repurposing Market will witness a robust CAGR of 7.6% , valued at USD 32.4 billion in 2024 , expected to appreciate and reach USD 50.3 billion by 2030Read More

Published Date: DEC-2025 | No Of Pages:168 | $ 4485

Peripheral Artery Disease (PAD) Market By Treatment Type (Pharmacological, Surgical, Endovascular); By Diagnostic Modality (ABI Testing, Ultrasound, CTA, MRA); By End User (Hospitals, Diagnostic Imaging Centers, ASCs, General Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peripheral Artery Disease (PAD) Market is expected to grow at a CAGR of 6.3% from 2024 to 2030, valued at USD 6.5 billion in 2024 , and projected to reach USD 10.2... Read More

Published Date: NOV-2025 | No Of Pages:191 | $ 4485

Adult Intraventricular Hemorrhage (IVH) Market By Diagnostic Modality (CT, MRI, Ultrasound); By Treatment Type (Surgical Intervention, Pharmaceutical Treatment, Rehabilitation Therapy); By End User (Hospitals, Rehabilitation Centers, Trauma Centers, Specialized Stroke Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Adult Intraventricular Hemorrhage (IVH) Market is projected to grow steadily, with an estimated value of USD 1.8 billion in 2024 , expected to reach Read More

Published Date: NOV-2025 | No Of Pages:173 | $ 4485

Light Therapy Market By Device Type (Full-body Light Boxes, Portable Devices, Wearable Units); By Application (Dermatology, Seasonal Affective Disorder, Neurological Rehabilitation, Sleep Disorders, Wound Healing); By End User (Hospitals & Clinics, Dermatology & Aesthetic Centers, Wellness Centers & Spas, Home Users); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Light Therapy Market will witness a steady CAGR of 5.8%, valued at USD 1.2 billion in 2024, expected to reach USD 1.68 billion by 2030, according to Strategic Market Research.

This market centers... Read More

Published Date: NOV-2025 | No Of Pages:178 | $ 4485

Orthobiologics Market By Product Type (Stem Cells, PRP, Growth Factors, Bone Grafts); By Application (Orthopedic Conditions, Sports Medicine, Spinal Surgery); By End User (Hospitals, ASCs, Specialized Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Orthobiologics Market is on a strong upward trajectory, projected to experience a CAGR of 8.4% , with a market size of approximately USD 7.1 billi... Read More

Published Date: NOV-2025 | No Of Pages:157 | $ 4485

Breast Conserving Surgery Market By Surgical Technique (Traditional, Robotic-Assisted, IORT, Partial Breast Radiation); By End-User (Hospitals, Oncology Clinics, ASCs, Diagnostic Imaging Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Breast Conserving Surgery (BCS) Market is positioned for steady growth, driven by rising awareness of breast cancer treatments that prioritize the preserv... Read More

Published Date: NOV-2025 | No Of Pages:177 | $ 4485

Dermal Regeneration Market By Product Type (Stem Cell Therapies, Growth Factor Therapies, Skin Substitutes, Wound Dressings); By Application (Burns, Chronic Wounds, Cosmetic Dermatology); By End User (Hospitals, Specialty Clinics, Home Healthcare, Rehabilitation Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Dermal Regeneration Market is poised for significant growth over the coming years, projected to reach a market value of USD 9.7 billion in 2024 , with an anticipated Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Circadian Rhythm Sleep Disorder Market By Disorder Type (Delayed Sleep Phase Disorder, Shift Work Sleep Disorder, Non-24-Hour Sleep-Wake Disorder, Advanced Sleep Phase Disorder, Jet Lag Disorder); By Treatment Type (Pharmacological, Light Therapy, Digital Therapeutics, Wearables); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By End User (Sleep Clinics, General Hospitals, Employers, Consumers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Circadian Rhythm Sleep Disorder Market is projected to reach USD 3.9 billion by 2030 , up from an estimated USD 2.2 billion in 2024 , growing at a CAGR of 9.5%Read More

Published Date: NOV-2025 | No Of Pages:183 | $ 4485

Immuno-Oncology Antibodies Market By Therapy Type (Monoclonal Antibodies, Bispecific Antibodies, IO-Active ADCs, CAR-T, TCR-T, NK & γδ-T Cell Therapies); By Cancer Type (Solid Tumors, Hematologic Malignancies); By Line of Therapy (First-Line, Second-Line, Later-Line); By Biomarker Class (PD-L1, MSI-H/dMMR, HER2, BCMA, GPRC5D, CLDN18.2 and Others); By Geography (United States, Europe, Asia-Pacific, Latin America), Segment Revenue Estimation & Forecast, 2025–2035

1. Introduction & Strategic Context

The Global Immuno-Oncology market for monoclonal antibodies & cell therapies expands from USD 55–60B in 2025 to ~USD 140B by 2035, propelled by deeper first-line penetration of PD-1/PD... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

Endometriosis and Uterine Fibroid Therapeutics Market By Therapy Type (Combined Oral Contraceptives, Progestogens & LNG-IUS, GnRH Agonists, Oral GnRH Antagonists, Emerging Non-Hormonal Therapies); By Disease Type (Endometriosis, Uterine Fibroids); By Distribution Channel (Hospitals & Surgical Centers, Specialty Gynecology Clinics, Retail & Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2025–2035.

1. Introduction and Strategic Context

The Global Endometriosis & Uterine Fibroid Therapeutics Market is entering a decade of accelerated growth, expanding from USD 1.60 billion in 2025 to USD 5.50 billion by 2035,... Read More

Published Date: NOV-2025 | No Of Pages:180 | $ 4485

Hadron Therapy Market By Treatment Type (Proton Therapy, Heavy Ion Therapy, Other Emerging Therapies); By Technology (Particle Accelerators, Treatment Planning Systems); By End User (Hospitals & Cancer Treatment Centers, Research & Academic Institutions, Contract Research Organizations, Government & Regulatory Bodies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hadron Therapy Market is poised for steady growth, with a projected Compound Annual Growth Rate (CAGR) of 7.3% from 2024 to 2030, expecte... Read More

Published Date: NOV-2025 | No Of Pages:182 | $ 4485

Long-Acting Injectables (LAIS) Market By Product Type (Injectable Depot Formulations, Implantable LAIs); By Therapeutic Application (Psychiatric Disorders, HIV Treatment, Chronic Pain Management, Endocrine Disorders, Others); By End-User (Hospitals, Clinics, Specialty Pharmacies, Contract Research Organizations, Primary Care Physicians); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Long-Acting Injectables (LAIS) Market is set to witness a significant rise, driven by increasing demand for advanced therapies with better patient compliance and reduced frequency of administration. Valued at Read More

Published Date: NOV-2025 | No Of Pages:181 | $ 4485

Spinal Cord Injury (SCI) Treatment Market By Treatment Type (Pharmaceuticals, Medical Devices, Stem Cell Therapies, Rehabilitation Technologies); By End User (Hospitals, Rehabilitation Centers, Home Care, CROs); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spinal Cord Injury (SCI) Treatment Market is poised for significant growth, with a CAGR of 7.4% , valued at USD 7.5 billion in 2024, and ... Read More

Published Date: NOV-2025 | No Of Pages:176 | $ 4485